Hologic's fiscal Q1 profits dive on Gen-Probe acquisition costs

February 4, 2013 by MassDevice staff

Profits for Hologic during its fiscal 1st quarter plunge some 85% as it digests its $4 billion merger with Gen-Probe and raises its earnings outlook for the full fiscal year.


Hologic (NSDQ:HOLX) saw its fiscal 1st-quarter profits plunge 85% on costs related to its $4 billion buyout of diagnostics giant Gen-Probe, despite nearly 34% top-line growth.

Get the complete picture with a MassDevice Plus membership. Registered users can login here.